Reaktionsgleichung
[S:1](=[O:5])(=[O:4])([OH:3])[OH:2].[CH2:6]([N:8]1[C:14](=[O:15])[C:13]([CH3:17])([CH3:16])[C:12](=[O:18])[N:11]([CH3:19])[C:10]2[CH:20]=[C:21]([O:24][CH2:25][CH2:26][CH2:27][NH:28][CH2:29][C:30]3[CH:35]=[CH:34][N:33]=[CH:32][CH:31]=3)[CH:22]=[CH:23][C:9]1=2)[CH3:7]>C(OCC)(=O)C>[S:1]([OH:5])([OH:4])(=[O:3])=[O:2].[CH2:6]([N:8]1[C:14](=[O:15])[C:13]([CH3:17])([CH3:16])[C:12](=[O:18])[N:11]([CH3:19])[C:10]2[CH:20]=[C:21]([O:24][CH2:25][CH2:26][CH2:27][NH:28][CH2:29][C:30]3[CH:31]=[CH:32][N:33]=[CH:34][CH:35]=3)[CH:22]=[CH:23][C:9]1=2)[CH3:7]Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
Sulfuric acid (13 μl) was added to an ethyl acetate solution (5 ml) of 1-ethyl-3,3,5-trimethyl-7-{3-[(pyridin-4-ylmethyl)amino]propoxy}-1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione (100 mg, 0.24 mmol), and stirred at room temperature for 15 minutes. The resultant mixture was concentrated to dryness under reduced pressure to thereby obtain 1-ethyl-3,3,5-trimethyl-7-{3-[(pyridin-4-ylmethyl)amino]propoxy}-1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione sulfate as a white amorphous solid.
Aufarbeitung
- concentrationThe resultant mixture was concentrated to dryness under reduced pressure to thereby obtain 1-ethyl-3,3,5-trimethyl-7-{3-[(pyridin-4-ylmethyl)amino]propoxy}-1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione sulfate as a white amorphous solid
Quellen und Nachweise
- ORD-Eintrag
- ord-8bfb4dd7d1894f44a543db574ea11c07
- Quelldatensatz
- uspto-grants-2014_03
- Patentnummer
- US08664217B2
Verknüpfte Notizen
Wird geladen…